The University of California, San Francisco Medical Center is a research and teaching hospital in San Francisco, California and is the medical center of the University of California, San Francisco. It is affiliated with the UCSF School of Medicine.

There are 796 beds in University of California, San Francisco Medical Center.

During the past decade, University of California, San Francisco Medical Center conducted 149 clinical trials. In the 10-year time frame, 149 clinical trials started and 101 clinical trials were completed, i.e. on average, 67.8% percent of trials that started reached the finish line to date. In the past 5 years, 59 clinical trials started and 44 clinical trials were completed. i.e. 74.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of California, San Francisco Medical Center" #1 sponsor was "University of California, San Francisco" with 39 trials, followed by "Children's Oncology Group" with 21 trials sponsored, "Novartis Pharmaceuticals" with 13 trials sponsored, "National Cancer Institute (NCI)" with 11 trials sponsored and "Pfizer" with 11 trials sponsored. Other sponsors include 182 different institutions and companies that sponsored additional 128 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California, San Francisco Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 9 trials as a collaborator, "Medical University of South Carolina" with 7 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 6 trials as a collaborator and "University of California, San Francisco" with 5 trials as a collaborator. Other collaborators include 217 different institutions and companies that were collaborators in the rest 178 trials.

According to Clinical.Site data, the most researched conditions in "University of California, San Francisco Medical Center" are "Pulmonary Arterial Hypertension" (9 trials), "Multiple Myeloma" (7 trials), "Unspecified Childhood Solid Tumor, Protocol Specific" (7 trials), "Hepatitis B" (6 trials) and "Acute Myeloid Leukemia" (5 trials). Many other conditions were trialed in "University of California, San Francisco Medical Center" in a lesser frequency.

Most popular intervention types in "University of California, San Francisco Medical Center" are "Drug" (166 trials), "Biological" (49 trials), "Other" (43 trials), "Device" (34 trials) and "Procedure" (30 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "laboratory biomarker analysis" (18 trials), "pharmacological study" (9 trials), "cyclophosphamide" (8 trials) and "etoposide" (7 trials). Other intervention names were less common.

The vast majority of trials in "University of California, San Francisco Medical Center" are 271 trials for "All" genders, 4 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "University of California, San Francisco Medical Center". undefined are not yet recruiting, 44 are recruiting, 38 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 153 completed trials in University of California, San Francisco Medical Center, 2 suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in University of California, San Francisco Medical Center, 51 "Phase 1" clinical trials were conducted, 82 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 42 trials that are defined as “Not Applicable".